Supernus Pharmaceuticals (SUPN)
NASDAQ:SUPN
Holding SUPN?
Track your performance easily

Supernus Pharmaceuticals (SUPN) Income Statement

476 Followers

Supernus Pharmaceuticals Income Statement

Last quarter (Q2 2024), Supernus Pharmaceuticals's total revenue was $168.32M, an increase of 9.47% from the same quarter last year. In Q2, Supernus Pharmaceuticals's net income was $19.92M. See Supernus Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 601.41M$ 607.52M$ 667.24M$ 579.77M$ 520.40M$ 392.75M
Cost of Revenue
$ 74.92M$ 83.78M$ 87.22M-$ 52.46M$ 16.66M
Gross Profit
$ 526.50M$ 523.74M$ 580.02M$ 579.77M$ 467.94M$ 376.10M
Operating Expense
$ 521.64M$ 510.34M$ 534.40M$ 500.28M$ 292.34M$ 227.52M
Operating Income
$ 10.76M$ -5.27M$ 46.12M$ 79.50M$ 175.60M$ 148.57M
Net Non Operating Interest Income Expense
$ -910.00K$ -1.32M$ -1.10M$ 19.70M$ -5.05M$ -1.08M
Other Income Expense
$ -15.37M$ 10.63M$ -15.13M$ 6.32M$ -1.90M-
Pretax Income
$ 19.31M$ 2.77M$ 60.74M$ 73.17M$ 168.65M$ 147.49M
Tax Provision
$ 16.07M$ 1.45M$ 32.00K$ 19.75M$ 41.70M$ 34.43M
Earnings From Equity Interest Net Of Tax
--$ 12.89M---
Net Income Common Stockholders
$ 3.23M$ 1.32M$ 60.71M$ 53.42M$ 126.95M$ 113.06M
Basic EPS
$ 0.05$ 0.02$ 1.13$ 1.01$ 2.41$ 2.16
Diluted EPS
$ 0.05$ 0.02$ 1.04$ 0.98$ 2.36$ 2.10
Basic Average Shares
$ 218.89M$ 54.54M$ 53.67M$ 53.10M$ 52.62M$ 52.41M
Diluted Average Shares
$ 220.46M$ 55.51M$ 61.68M$ 54.36M$ 53.69M$ 53.82M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 596.56M$ 594.12M$ 621.62M$ 500.28M$ 344.80M$ 244.18M
Net Income From Continuing And Discontinued Operation
$ 3.23M$ 1.32M$ 60.71M$ 53.42M$ 126.95M$ 113.06M
Normalized Income
$ -4.45M$ 20.86M$ 47.48M-$ 128.38M$ 113.06M
Interest Expense
----$ 23.75M$ 22.71M
EBIT
$ 20.22M$ 4.09M$ 67.81M$ 44.68M$ 192.40M$ 170.19M
EBITDA
$ 104.30M$ 89.48M$ 153.36M$ 94.77M$ 210.54M$ 176.85M
Currency in USD

Supernus Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis